Jaromír Gumulec

Deputy Head Physician for Health Care
Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava
Ostrava, Moravskoslezsky kraj, Czech Republic

Presentation(s):

• OC 65.1 - Long-Term Efficacy and Safety With Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients With Immune Thrombocytopenia

  Tuesday, June 27, 2023
  14:45 – 15:00 ET